DIO1 (Gene)

Organism:

Homo sapiens

Synonyms:5DI, DIO1, ENTREZ:1733, HGNC:2883, MIM:147892, NM_000792, NM_001039715, NM_001039716, NM_001324316, NM_213593, NP_000783, NP_001034804, NP_001034805, NP_001311245, NP_998758, NR_136692, NR_136693, TXDI1, iodothyronine deiodinase 1

Omim:OMIM:147892

Id:80cba3b9-eac0-5cb9-b17d-bf76daac1915

Hgnc:HGNC:2883

Entrez:1733

Ensembl:ENSG00000211452

Description:iodothyronine deiodinase 1

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View DIO1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with DIO1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using DIO1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for DIO1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with DIO1.

Results found

Linked to

	Label	Description
	GSE239688 canagliflozin 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 4 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 7 v 13 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE133087 metformin 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE98856 adenosine 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147613 1 V 0 CISPLATIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE125014 enzalutamide prostate gland 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE157594 6 V 2 NICOTINAMIDE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

GSE239688 canagliflozin 4 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE48812 sulforaphane 4 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 7 v 13 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE133087 metformin 1 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE98856 adenosine 3 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE147613 1 V 0 CISPLATIN MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE125014 enzalutamide prostate gland 1 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 3 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE157594 6 V 2 NICOTINAMIDE MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.